Skip to content
777 Sourcing.

Capability

alternative splicing

Suppliers
1
States & provinces
1
Countries
1

1 alternative splicing supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Aletira is developing gene therapies that use alternative splicing to control where gene expression occurs. Its selective exon, SELEXON(TM), technology harnesses alternative splicing to enable cell-type selective gene expression in therapeutic constructs. SELEXONs can be incorporated into any gene therapy platform (e.g., AAV) to ensure gene products are expressed in target cells and avoid off-target expression, improving safety, increasing potency, and accelerating development.

AIcell-type selective gene expressioncomputational biologygene therapy

Related capabilities

Other processes offered by the shops that list alternative splicing.

Browse all capabilities